SCHEMBL1219005

SCHEMBL1219005

CC(C)(C)[C@H](NC(=O)O)C(=O)NCC(N)=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 1/20 0.38
MMP3 P08254 11/20 0.33
MMP2 P08253 11/20 0.33
MMP1 P03956 10/20 0.33
MMP7 P09237 3/20 0.33
ECE1 P42892 3/20 0.33
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
PTGS2 P35354 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CTSK P43235 1/20 0.32
MMP9 P14780 6/20 0.32
MMP8 P22894 4/20 0.32
MMP13 P45452 3/20 0.32
MMP14 P50281 2/20 0.31
ADAM17 P78536 2/20 0.31
MMP20 O60882 1/20 0.31
ADAMTS4 O75173 1/20 0.31
TNF P01375 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15840402 0.81 METAP1 (0.35) METAP1MMP3MMP2MMP1MMP7
SCHEMBL1215890 0.80 MAOA (0.47) METAP1CTSK
SCHEMBL11972170 0.76 USP2 (0.45) MMP3MMP2MMP1MMP7ALDH1A1
SCHEMBL4676064 0.75 HIF1A (0.37) MMP3MMP2MMP1MMP7MMP9
SCHEMBL3556829 0.75 HIF1A (0.37) MMP3MMP2MMP1MMP7MMP9
SCHEMBL27145161 0.74 CNR2 (0.36) MMP9
SCHEMBL21543027 0.74 CNR2 (0.36) MMP9
SCHEMBL2784044 0.74 CNR2 (0.36) MMP9
SCHEMBL12884692 0.73 DPP4 (0.43) METAP1ECE1ALDH1A1LMNAMAPT
SCHEMBL8690110 0.72 MMP3 (0.35) MMP3MMP2MMP1MMP7MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110028447-A1 INDAZOLE DERIVATIVES PFIZER INC. 2011-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028447-A1 INDAZOLE DERIVATIVES CNR1, CNR2, GPR119 METAP1 4497/4885MMP3 3964/4885MMP2 4786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.